Cotrimoxazole in the treatment of serous otitis. A follow-up report.
D002648:Child; D002744:Chlorpheniramine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D057985:Multi-Ingredient Cold, Flu, and Allergy Medications; D010033:Otitis Media / Q000188:drug therapy*; D010034:Otitis Media with Effusion / Q000188:drug therapy*; D010656:Phenylephrine / Q000627:therapeutic use; D010665:Phenylpropanolamine / Q000627:therapeutic use; D011897:Random Allocation; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D004338:Drug Combinations; D057985:Multi-Ingredient Cold, Flu, and Allergy Medications; C037668:chlorpheniramine, phenylephrine, phenylpropanolamine drug combination; D010656:Phenylephrine; D010665:Phenylpropanolamine; D002744:Chlorpheniramine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole